ArticleJournal of diabetes science and technology2013
Performance evaluations of continuous glucose monitoring systems: precision absolute relative deviation is part of the assessment.
Article in Journal of diabetes science and technology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed.
- Accuracy and reliability of a subcutaneous continuous glucose monitoring device in critically ill patients.Journal of clinical monitoring and computing · 2018Trial
- A Comprehensive Performance Evaluation of Five Blood Glucose Systems in the Hypo-, Eu-, and Hyperglycemic Range.Journal of diabetes science and technology · 2016Trial
- Accuracy of a novel noninvasive transdermal continuous glucose monitor in critically ill patients.Journal of diabetes science and technology · 2014Trial
- Evaluation of the performance of a novel system for continuous glucose monitoring.Journal of diabetes science and technology · 2013Trial
- Performance evaluation of three continuous glucose monitoring systems: comparison of six sensors per subject in parallel.Journal of diabetes science and technology · 2013Trial
- Performance evaluation of a continuous glucose monitoring system under conditions similar to daily life.Journal of diabetes science and technology · 2013Trial
- Article
- Continuous Biosensor Based on Particle Motion: How Does the Concentration Measurement Precision Depend on Time Scale?ACS sensors · 2024Article
- Impact of Bindarit, a CCL2 Chemokine Synthesis Inhibitor, on Macrophage-Based Biofouling and Continuous Glucose MonitoringBiosensors & bioelectronics: X · 2024Article
- Accuracy of continuous glucose monitoring during exercise-related hypoglycemia in individuals with type 1 diabetes.Frontiers in endocrinology · 2024Article
- Analytical Performance of the Factory-Calibrated Flash Glucose Monitoring System FreeStyle Libre2Sensors (Basel, Switzerland) · 2023Article
- Clinical Use of a 180-Day Implantable Glucose Monitoring System in Dogs with Diabetes Mellitus: A Case Series.Animals : an open access journal from MDPI · 2022Article
- Effect of postprandial moderate-intensity walking for 15-min on glucose homeostasis in type 2 diabetes mellitus patients.Diabetology international · 2020Article
- Benefits and Limitations of MARD as a Performance Parameter for Continuous Glucose Monitoring in the Interstitial Space.Journal of diabetes science and technology · 2020Article
- Multivariable Artificial Pancreas for Various Exercise Types and Intensities.Diabetes technology & therapeutics · 2018Article
- Limits to the Evaluation of the Accuracy of Continuous Glucose Monitoring Systems by Clinical Trials.Biosensors · 2018Article
- Crosslinked basement membrane-based coatings enhance glucose sensor function and continuous glucose monitoring in vivo.Journal of biomedical materials research. Part A · 2018Article
- International Consensus on Use of Continuous Glucose Monitoring.Diabetes care · 2017Review
- Extensive Assessment of Blood Glucose Monitoring During Postprandial Period and Its Impact on Closed-Loop Performance.Journal of diabetes science and technology · 2017Article
- Accuracy and Time Delay of Glucose Measurements of Continuous Glucose Monitoring and Bedside Artificial Pancreas During Hyperglycemic and Euglycemic Hyperinsulinemic Glucose Clamp Study.Journal of diabetes science and technology · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEven though a Clinical and Laboratory Standards Institute proposal exists on the design of studies and performance criteria for continuous glucose monitoring (CGM) systems, it has not yet led to a consistent evaluation of different systems, as no consensus has been reached on the reference method to evaluate them or on acceptance levels. As a consequence, performance assessment of CGM systems tends to be inconclusive, and a comparison of the outcome of different studies is difficult. MATERIALS AND
methodsPublished information and available data (as presented in this issue of Journal of Diabetes Science and Technology by Freckmann and coauthors) are used to assess the suitability of several frequently used methods [International Organization for Standardization, continuous glucose error grid analysis, mean absolute relative deviation (MARD), precision absolute relative deviation (PARD)] when assessing performance of CGM systems in terms of accuracy and precision.
resultsThe combined use of MARD and PARD seems to allow for better characterization of sensor performance. The use of different quantities for calibration and evaluation, e.g., capillary blood using a blood glucose (BG) meter versus venous blood using a laboratory measurement, introduces an additional error source. Using BG values measured in more or less large intervals as the only reference leads to a significant loss of information in comparison with the continuous sensor signal and possibly to an erroneous estimation of sensor performance during swings. Both can be improved using data from two identical CGM sensors worn by the same patient in parallel.
conclusionsEvaluation of CGM performance studies should follow an identical study design, including sufficient swings in glycemia. At least a part of the study participants should wear two identical CGM sensors in parallel. All data available should be used for evaluation, both by MARD and PARD, a good PARD value being a precondition to trust a good MARD value. Results should be analyzed and presented separately for clinically different categories, e.g., hypoglycemia, exercise, or night and day.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.